FDA Inspection 1114915 — NuCare Pharmaceuticals Inc

NuCare Pharmaceuticals Inc — FEI 3003294404

The FDA completed an inspection of NuCare Pharmaceuticals Inc on January 10, 2020 in Orange, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 10, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Orange, CA (United States)

Citations

IDCFRDescription
176721 CFR 211.137(a)Expiration date lacking